- Nagalase causes immunodeficiency. Nagalase blocks production of MAF, thus preventing the immune system from doing its job. Without an active immune system, cancer and viral infections can grow unchecked.
- As an extremely sensitive marker for all cancers, Nagalase provides a powerful system for early detection.
- Serial Nagalase testing provides a reliable and accurate method for tracking the results of any therapeutic regimen for cancer, AIDS, or other chronic viral infection.
Virus particles also make Nagalase. Their goal is the same as that of the cancer cells: survival by incapacitating their number one enemy: the immune system.
Nagalase’s behaviour toward us has been reprehensible and disastrous. Working in cahoots with cancer and HIV—not shy about getting into bed with our mortal enemies—Nagalase can rightfully claim direct responsibility for billions of human deaths. And it would just as soon add you to the list.
Nagalase is a “genocidal murderer” and yet so few people have heard of it and even fewer laboratories (6 at the last count) offer a test to measure the levels of Nagalase in the blood.
Rising Nagalase levels indicate a cancer or virus is growing and spreading. Conversely, Nagalase levels will decrease if the cancer or infection is being effectively destroyed.
Any treatment that lowers cancer cell (or viral numbers) will lower Nagalase levels.
Nagalase will, for example, always drop after surgery (whether or not the entire tumour was removed). Chemotherapy and radiation also reduce Nagalase levels. So does MAF.
If, after these treatments, the depressed level begins to rise again, this is the warning sign that the cancer was not completely removed, and/or that metastatic disease is hiding out somewhere. With viral infections, increasing Nagalase levels indicate return of the infection.
Consecutive rising Nagalase levels are therefore a red flag, warning us it may be time to entertain new treatment options. Conversely, if levels are going down, stay the course: the cancer or virus is going away.